Pair Name | All-trans retinoic acid, Decitabine | ||
Phytochemical Name | All-trans retinoic acid (PubChem CID: 444795 ) | ||
Anticancer drug Name | Decitabine (PubChem CID: 451668 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | All-trans retinoic acid, Decitabine | |||
Disease Info | [ICD-11: 2A60.Z] | Acute myeloid leukemia | Investigative | |
Biological Phenomena | Induction-->ROS accumulation | |||
Gene Regulation | Up-regulation | Cleavage | CASP3 | hsa836 |
Down-regulation | Expression | DUSP1 | hsa1843 | |
Down-regulation | Expression | FTH1 | hsa2495 | |
Down-regulation | Expression | GPX2 | hsa2877 | |
Up-regulation | Expression | NFE2L2 | hsa4780 | |
Down-regulation | Expression | NQO1 | hsa1728 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Up-regulation | Activity | RARA | hsa5914 | |
In Vitro Model | MDS | Childhood T acute lymphoblastic leukemia | Homo sapiens (Human) | CVCL_L807 |
MOLM-13 | Adult acute myeloid leukemia | Homo sapiens (Human) | CVCL_2119 | |
In Vivo Model | 1×10⁶ MOLM-13-Luciferase (MOLM-13-Luc) cells were injected via the tail veins to establish the cell line-derived xenograft (CDX) model. | |||
Result | These results demonstrate that combining DAC and ATRA has potential for the clinical treatment of HR-MDS/AML and merits further exploration. |
No. | Title | Href |
---|---|---|
1 | All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex. Br J Cancer. 2023 Feb;128(4):691-701. doi: 10.1038/s41416-022-02074-0. | Click |